IDEXX Laboratories, Inc. (IDXX)
| Market Cap | 57.02B |
| Revenue (ttm) | 4.17B |
| Net Income (ttm) | 1.03B |
| Shares Out | 79.85M |
| EPS (ttm) | 12.60 |
| PE Ratio | 56.67 |
| Forward PE | 51.16 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 386,582 |
| Open | 720.72 |
| Previous Close | 717.47 |
| Day's Range | 710.51 - 722.71 |
| 52-Week Range | 356.14 - 769.98 |
| Beta | 1.67 |
| Analysts | Buy |
| Price Target | 683.89 (-4.23%) |
| Earnings Date | Nov 3, 2025 |
About IDXX
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference... [Read more]
Financial Performance
In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price target is $683.89, which is a decrease of -4.23% from the latest price.
News
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may b...
Baron Asset Fund Q3 2025 Performance Review
Baron Asset Fund underperformed for a second consecutive quarter as U.S. equities continued their strong rally from the market lows reached on April 8. From a sector perspective, stock selection in IT...
IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects
IDEXX Laboratories (IDXX) continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21...
Why Idexx Laboratories Stock Surged by Almost 15% Today
It notched a beat-and-raise third quarter. It cited innovation and increased customer take-up as reasons for the solid growth it posted during the frame.
Final Trades: Meta, S&P Global and Idexx Lab
The Investment Committee give you their top stocks to watch for the second half.
IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. ( IDXX) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jay Mazelsky - President, CEO & Director Confer...
Idexx Stock Pops on Earnings. Pet Health Is Booming.
Vet visits are down, but growing revenue per visit is more than making up for it, the company says.
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook
IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast.
IDEXX raises annual forecasts as pet owners spend more on preventive care
IDEXX Laboratories raised its full-year profit and revenue forecasts on Monday after reporting better third-quarter results than last year, as the pet diagnostics maker banks on owners spending more o...
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company repor...
IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
IDEXX Laboratories, Inc. (NASDAQ:IDXX) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3.
Seilern Investment Management Sells $43 Million Worth of IDEXX Laboratories (NASDAQ: IDXX) Stock
Seilern Investment Management Ltd disclosed the sale of 70,900 shares of IDEXX Laboratories for the period ended September 30, 2025, an estimated $43.03 million trade based on the average price for Q3...
IDEXX Laboratories to Release 2025 Third Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Mond...
IDEXX Laboratories Elects Karen Peacock to Board of Directors
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Direct...
These Were the 3 Top-Performing Stocks in the Nasdaq-100 in August 2025
The Nasdaq-100 traded almost exactly sideways in August 2025, posting a 0.9% gain. But it wasn't a slow period for everybody.
IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:50 PM EDT Company Participants Jay Mazelsky - President, CEO & Director Andrew Emers...
These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025
If you buy a stock that goes up 20% in a year, I'd say you made a good investment. After all, the S&P 500 (^GSPC 0.51%) returns somewhere around 10% annually on average.
These Were the 3 Top-Performing Stocks in the Nasdaq Composite in August 2025
The Nasdaq Composite (^IXIC -0.82%) is one of the U.S. stock market's three major indexes, along with the S&P 500 and Dow Jones. It contains virtually every stock listed on the Nasdaq stock exchange a...
IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes
Major U.S. equities indexes pushed higher at the top of the new trading week, bouncing back from declines posted ahead of the weekend. Although weaker-than-expected jobs data released on Friday raised...
IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jonathan J. Mazelsky - President,...
Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF
The Investment Committee gives you their top stocks to watch for the second half.
Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More
U.S. equities were higher at midday, bouncing back from Friday's employment report-related selloff, and on news the European Union would delay new tariffs on U.S. goods. The Dow Jones Industrial Avera...
IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation
Pet healthcare is witnessing a surge in demand as more households prioritize their pets' well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Labor...